American Century Companies Inc. Has $45.92 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

American Century Companies Inc. reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 3.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 532,710 shares of the company’s stock after selling 20,943 shares during the quarter. American Century Companies Inc. owned approximately 0.61% of HealthEquity worth $45,920,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. AGF Management Ltd. raised its position in shares of HealthEquity by 7.3% during the second quarter. AGF Management Ltd. now owns 29,245 shares of the company’s stock worth $2,521,000 after acquiring an additional 1,985 shares during the last quarter. Texas Permanent School Fund Corp raised its holdings in HealthEquity by 3.1% during the 2nd quarter. Texas Permanent School Fund Corp now owns 77,424 shares of the company’s stock worth $6,674,000 after purchasing an additional 2,332 shares during the last quarter. Van Berkom & Associates Inc. lifted its position in shares of HealthEquity by 1.8% in the 2nd quarter. Van Berkom & Associates Inc. now owns 930,168 shares of the company’s stock worth $80,180,000 after purchasing an additional 16,807 shares during the period. Choreo LLC boosted its stake in shares of HealthEquity by 61.0% in the 2nd quarter. Choreo LLC now owns 20,537 shares of the company’s stock valued at $1,779,000 after purchasing an additional 7,780 shares during the last quarter. Finally, Prudential PLC acquired a new stake in shares of HealthEquity during the second quarter worth $2,429,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 0.0 %

HQY opened at $78.25 on Tuesday. HealthEquity, Inc. has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The firm has a market capitalization of $6.83 billion, a PE ratio of 85.05, a P/E/G ratio of 1.19 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The company’s 50-day moving average is $76.21 and its 200 day moving average is $79.42.

Analyst Ratings Changes

HQY has been the topic of several recent analyst reports. Raymond James boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Friday, June 7th. JMP Securities restated a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Wells Fargo & Company raised their target price on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday, June 20th. Robert W. Baird boosted their price target on HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Finally, Bank of America reduced their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $103.83.

Insiders Place Their Bets

In other news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now owns 6,070 shares in the company, valued at $497,072.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares in the company, valued at approximately $19,231,138.08. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the transaction, the director now directly owns 6,070 shares in the company, valued at approximately $497,072.30. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,031 shares of company stock valued at $6,103,625. Corporate insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.